Yuanqing Ma

About Yuanqing Ma

Yuanqing Ma, With an exceptional h-index of 9 and a recent h-index of 8 (since 2020), a distinguished researcher at University of Texas Southwestern Medical Center, specializes in the field of Renal Cell Carcinoma.

His recent articles reflect a diverse array of research interests and contributions to the field:

HIF2 inactivation and tumor suppression with a tumor-directed RNA-silencing drug in mice and humans

Targeting HIF2a with siRNA: From preclinical models to the clinic

Determinants of renal cell carcinoma invasion and metastatic competence

Pancreatic tropism of metastatic renal cell carcinoma

HIF-2 complex dissociation, target inhibition, and acquired resistance with PT2385, a first-in-class HIF-2 inhibitor, in patients with clear cell renal cell carcinoma

Yuanqing Ma Information

University

Position

___

Citations(all)

1076

Citations(since 2020)

856

Cited By

521

hIndex(all)

9

hIndex(since 2020)

8

i10Index(all)

9

i10Index(since 2020)

7

Email

University Profile Page

Google Scholar

Yuanqing Ma Skills & Research Interests

Renal Cell Carcinoma

Top articles of Yuanqing Ma

HIF2 inactivation and tumor suppression with a tumor-directed RNA-silencing drug in mice and humans

Clinical Cancer Research

2022/12/15

Targeting HIF2a with siRNA: From preclinical models to the clinic

Cancer Research

2022/6/15

HIF-2 complex dissociation, target inhibition, and acquired resistance with PT2385, a first-in-class HIF-2 inhibitor, in patients with clear cell renal cell carcinoma

Clinical Cancer Research

2020/2/15

See List of Professors in Yuanqing Ma University(University of Texas Southwestern Medical Center)